

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phospholipid homeostasis (GO:0055091) | 4.24047764 |
| 2 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.48303283 |
| 3 | macroautophagy (GO:0016236) | 3.36729341 |
| 4 | interkinetic nuclear migration (GO:0022027) | 3.28783385 |
| 5 | carnitine shuttle (GO:0006853) | 3.26492195 |
| 6 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.26231976 |
| 7 | fatty acid transmembrane transport (GO:1902001) | 3.25134867 |
| 8 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.20359455 |
| 9 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.18748802 |
| 10 | histone H3-K36 demethylation (GO:0070544) | 3.13544337 |
| 11 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.02923369 |
| 12 | nucleus localization (GO:0051647) | 3.02819999 |
| 13 | urea metabolic process (GO:0019627) | 2.98589546 |
| 14 | urea cycle (GO:0000050) | 2.98589546 |
| 15 | negative regulation of myotube differentiation (GO:0010832) | 2.95999164 |
| 16 | cellular response to epinephrine stimulus (GO:0071872) | 2.95742776 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.92159343 |
| 18 | establishment of nucleus localization (GO:0040023) | 2.91770963 |
| 19 | regulation of sequestering of triglyceride (GO:0010889) | 2.88461809 |
| 20 | desmosome organization (GO:0002934) | 2.85685401 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 2.85624397 |
| 22 | histone H3-K9 demethylation (GO:0033169) | 2.84281961 |
| 23 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.83507249 |
| 24 | histone H3-K4 trimethylation (GO:0080182) | 2.82652566 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.80595415 |
| 26 | myofibril assembly (GO:0030239) | 2.79759679 |
| 27 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.76955229 |
| 28 | skeletal muscle adaptation (GO:0043501) | 2.76851832 |
| 29 | lipoprotein transport (GO:0042953) | 2.75255461 |
| 30 | growth hormone receptor signaling pathway (GO:0060396) | 2.74323660 |
| 31 | hemidesmosome assembly (GO:0031581) | 2.74268043 |
| 32 | establishment of protein localization to Golgi (GO:0072600) | 2.74014708 |
| 33 | cell-substrate junction assembly (GO:0007044) | 2.70210746 |
| 34 | response to epinephrine (GO:0071871) | 2.69287911 |
| 35 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.67769410 |
| 36 | phospholipid translocation (GO:0045332) | 2.67299935 |
| 37 | lipid translocation (GO:0034204) | 2.67299935 |
| 38 | peptidyl-threonine phosphorylation (GO:0018107) | 2.66926982 |
| 39 | regulation of ARF protein signal transduction (GO:0032012) | 2.66540403 |
| 40 | positive regulation of fatty acid oxidation (GO:0046321) | 2.64878391 |
| 41 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.64218050 |
| 42 | positive regulation of lipid catabolic process (GO:0050996) | 2.63133744 |
| 43 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.62612870 |
| 44 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.61911770 |
| 45 | import into cell (GO:0098657) | 2.59843779 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.59728035 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 2.58918382 |
| 48 | positive regulation of p38MAPK cascade (GO:1900745) | 2.58248419 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.58145244 |
| 50 | nerve growth factor signaling pathway (GO:0038180) | 2.56024019 |
| 51 | carnitine transmembrane transport (GO:1902603) | 2.55980453 |
| 52 | protein targeting to Golgi (GO:0000042) | 2.55910787 |
| 53 | striated muscle atrophy (GO:0014891) | 2.55865584 |
| 54 | cardiac myofibril assembly (GO:0055003) | 2.54328997 |
| 55 | peptidyl-threonine modification (GO:0018210) | 2.53380378 |
| 56 | regulation of cholesterol storage (GO:0010885) | 2.52171018 |
| 57 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.52072782 |
| 58 | I-kappaB phosphorylation (GO:0007252) | 2.52070513 |
| 59 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.51197589 |
| 60 | homocysteine metabolic process (GO:0050667) | 2.50908385 |
| 61 | cellular response to growth hormone stimulus (GO:0071378) | 2.50110621 |
| 62 | Golgi to endosome transport (GO:0006895) | 2.49755472 |
| 63 | establishment of skin barrier (GO:0061436) | 2.49414906 |
| 64 | iron ion import (GO:0097286) | 2.47230382 |
| 65 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.45643140 |
| 66 | hypotonic response (GO:0006971) | 2.45156490 |
| 67 | carnitine transport (GO:0015879) | 2.43545065 |
| 68 | amino-acid betaine transport (GO:0015838) | 2.43545065 |
| 69 | positive regulation of Rap GTPase activity (GO:0032854) | 2.43446162 |
| 70 | L-amino acid import (GO:0043092) | 2.42710449 |
| 71 | phospholipid efflux (GO:0033700) | 2.41971304 |
| 72 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.40154416 |
| 73 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.39835410 |
| 74 | regulation of triglyceride catabolic process (GO:0010896) | 2.39124046 |
| 75 | embryonic process involved in female pregnancy (GO:0060136) | 2.38894816 |
| 76 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.38742208 |
| 77 | lysine metabolic process (GO:0006553) | 2.37383246 |
| 78 | lysine catabolic process (GO:0006554) | 2.37383246 |
| 79 | negative regulation of cell killing (GO:0031342) | 2.37336983 |
| 80 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.37336983 |
| 81 | regulation of cholesterol homeostasis (GO:2000188) | 2.36886787 |
| 82 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.36647686 |
| 83 | low-density lipoprotein particle clearance (GO:0034383) | 2.36202836 |
| 84 | coronary vasculature morphogenesis (GO:0060977) | 2.35750759 |
| 85 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.34712863 |
| 86 | histone lysine demethylation (GO:0070076) | 2.34545273 |
| 87 | nuclear pore complex assembly (GO:0051292) | 2.34522754 |
| 88 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.34394606 |
| 89 | relaxation of cardiac muscle (GO:0055119) | 2.33314369 |
| 90 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.32168349 |
| 91 | regulation of fatty acid oxidation (GO:0046320) | 2.32014833 |
| 92 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.31769034 |
| 93 | kynurenine metabolic process (GO:0070189) | 2.31306714 |
| 94 | cell-substrate adherens junction assembly (GO:0007045) | 2.31060869 |
| 95 | focal adhesion assembly (GO:0048041) | 2.31060869 |
| 96 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.30495221 |
| 97 | positive regulation of cholesterol efflux (GO:0010875) | 2.30449523 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 2.29686410 |
| 99 | complement activation, alternative pathway (GO:0006957) | 2.29658702 |
| 100 | plasma lipoprotein particle clearance (GO:0034381) | 2.29645941 |
| 101 | regulation of p38MAPK cascade (GO:1900744) | 2.29233380 |
| 102 | regulation of water loss via skin (GO:0033561) | 2.28703817 |
| 103 | regulation of gamma-delta T cell activation (GO:0046643) | 2.28402402 |
| 104 | alanine transport (GO:0032328) | 2.28098887 |
| 105 | regulation of histone H3-K27 methylation (GO:0061085) | 2.27725483 |
| 106 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.27582286 |
| 107 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.26465086 |
| 108 | 2-oxoglutarate metabolic process (GO:0006103) | 2.26349706 |
| 109 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.26336169 |
| 110 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.26261777 |
| 111 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.25924106 |
| 112 | vesicle transport along microtubule (GO:0047496) | 2.25889754 |
| 113 | activation of protein kinase A activity (GO:0034199) | 2.24480976 |
| 114 | positive regulation of cholesterol transport (GO:0032376) | 2.24074738 |
| 115 | positive regulation of sterol transport (GO:0032373) | 2.24074738 |
| 116 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.23387384 |
| 117 | sodium ion export (GO:0071436) | 2.23157097 |
| 118 | intracellular lipid transport (GO:0032365) | 2.22423752 |
| 119 | regulation of relaxation of muscle (GO:1901077) | 2.22115028 |
| 120 | cholesterol efflux (GO:0033344) | 2.21736116 |
| 121 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.21534659 |
| 122 | regulation of RNA export from nucleus (GO:0046831) | 2.21299494 |
| 123 | positive regulation of glycolytic process (GO:0045821) | 2.21271406 |
| 124 | histone demethylation (GO:0016577) | 2.21260233 |
| 125 | regulation of Rap GTPase activity (GO:0032317) | 2.21245117 |
| 126 | cell communication involved in cardiac conduction (GO:0086065) | 2.20232302 |
| 127 | cardiac muscle contraction (GO:0060048) | 2.20004443 |
| 128 | adherens junction assembly (GO:0034333) | 2.19990557 |
| 129 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.19955624 |
| 130 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.19232635 |
| 131 | fatty acid beta-oxidation (GO:0006635) | 2.19229458 |
| 132 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.17864949 |
| 133 | regulation of actin filament-based movement (GO:1903115) | 2.17740440 |
| 134 | protein-lipid complex assembly (GO:0065005) | 2.17300528 |
| 135 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.16946391 |
| 136 | fibroblast migration (GO:0010761) | 2.16867702 |
| 137 | cardiac muscle hypertrophy (GO:0003300) | 2.16006553 |
| 138 | positive regulation of histone deacetylation (GO:0031065) | 2.14239164 |
| 139 | plasma membrane repair (GO:0001778) | 2.14086818 |
| 140 | reverse cholesterol transport (GO:0043691) | 2.13881419 |
| 141 | cell communication by electrical coupling (GO:0010644) | 2.13738493 |
| 142 | regulation of beta-amyloid formation (GO:1902003) | 2.13580508 |
| 143 | regulation of protein polyubiquitination (GO:1902914) | 2.13435504 |
| 144 | L-phenylalanine catabolic process (GO:0006559) | 2.12735903 |
| 145 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.12735903 |
| 146 | tryptophan metabolic process (GO:0006568) | 2.12728777 |
| 147 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.12704554 |
| 148 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.12704554 |
| 149 | modulation by symbiont of host immune response (GO:0052553) | 2.12704554 |
| 150 | positive regulation by symbiont of host defense response (GO:0052509) | 2.12704554 |
| 151 | modulation by symbiont of host defense response (GO:0052031) | 2.12704554 |
| 152 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.12704554 |
| 153 | aromatic amino acid family catabolic process (GO:0009074) | 2.12193292 |
| 154 | indole-containing compound catabolic process (GO:0042436) | 2.11904742 |
| 155 | indolalkylamine catabolic process (GO:0046218) | 2.11904742 |
| 156 | tryptophan catabolic process (GO:0006569) | 2.11904742 |
| 157 | regulation of necroptotic process (GO:0060544) | 2.11859101 |
| 158 | glucan catabolic process (GO:0009251) | 2.11829093 |
| 159 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.11821296 |
| 160 | valine metabolic process (GO:0006573) | 2.11763824 |
| 161 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.11378335 |
| 162 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.11067259 |
| 163 | striated muscle adaptation (GO:0014888) | 2.10684165 |
| 164 | phospholipid dephosphorylation (GO:0046839) | 2.10140180 |
| 165 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.10103291 |
| 166 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.09926535 |
| 167 | negative regulation of lipase activity (GO:0060192) | 2.08766681 |
| 168 | negative regulation of lipid storage (GO:0010888) | 2.07117045 |
| 169 | muscle atrophy (GO:0014889) | 2.06788933 |
| 170 | diacylglycerol metabolic process (GO:0046339) | 2.06694645 |
| 171 | negative regulation of fatty acid transport (GO:2000192) | 2.06523409 |
| 172 | actomyosin structure organization (GO:0031032) | 2.05931826 |
| 173 | peptidyl-serine phosphorylation (GO:0018105) | 2.05825613 |
| 174 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.05488710 |
| 175 | cellular response to ethanol (GO:0071361) | 2.05446562 |
| 176 | striated muscle hypertrophy (GO:0014897) | 2.05388899 |
| 177 | fatty acid homeostasis (GO:0055089) | 2.05134760 |
| 178 | cellular response to catecholamine stimulus (GO:0071870) | 2.04835274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.78227725 |
| 2 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.40196498 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37073397 |
| 4 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.35963833 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.28005171 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.09223872 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04614515 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98728604 |
| 9 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.95852729 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.83978706 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79832249 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.75611019 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75447659 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.71788553 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71648434 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71499708 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70327796 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.70074260 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.69724988 |
| 20 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62457637 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.51341445 |
| 22 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.48446564 |
| 23 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46315414 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45618991 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45317541 |
| 26 | TP53_16413492_ChIP-PET_HCT116_Human | 1.44286980 |
| 27 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43505601 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38136674 |
| 29 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37638942 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34574837 |
| 31 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33687336 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.32905322 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32084883 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29613692 |
| 35 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.29501087 |
| 36 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.29328710 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28216724 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27701463 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.26510966 |
| 40 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26040580 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24551898 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23820145 |
| 43 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.23783097 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23062818 |
| 45 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19843435 |
| 46 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.19358137 |
| 47 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19268368 |
| 48 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18801528 |
| 49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18652804 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18640726 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17521640 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16966662 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16240646 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14165897 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.13060836 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12119275 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11195280 |
| 58 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11037707 |
| 59 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10906842 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10838778 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10702625 |
| 62 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10635481 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10110922 |
| 64 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09418870 |
| 65 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09241954 |
| 66 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.08614506 |
| 67 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08330612 |
| 68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05766556 |
| 69 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05766556 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05217721 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04265806 |
| 72 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04001808 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03948052 |
| 74 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03174922 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01606296 |
| 76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01044482 |
| 77 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01029118 |
| 78 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00961436 |
| 79 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00961436 |
| 80 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00954307 |
| 81 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00762942 |
| 82 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.99575564 |
| 83 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99509099 |
| 84 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98514119 |
| 85 | AR_19668381_ChIP-Seq_PC3_Human | 0.98393621 |
| 86 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97345392 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97158930 |
| 88 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.95211174 |
| 89 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95192413 |
| 90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95121350 |
| 91 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95055711 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94692766 |
| 93 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.94406737 |
| 94 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94007251 |
| 95 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93521288 |
| 96 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93044576 |
| 97 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.92883472 |
| 98 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92252761 |
| 99 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92133591 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91846554 |
| 101 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.91778143 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91526568 |
| 103 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91496190 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91402011 |
| 105 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91319065 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91266162 |
| 107 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90974287 |
| 108 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.90458021 |
| 109 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.89975588 |
| 110 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.89926536 |
| 111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89036587 |
| 112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89036587 |
| 113 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.85727415 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 0.85659634 |
| 115 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85223926 |
| 116 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.85135969 |
| 117 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84692155 |
| 118 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.84218125 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83988284 |
| 120 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83405053 |
| 121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81512351 |
| 122 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.81388148 |
| 123 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.80826057 |
| 124 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80250723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.21711331 |
| 2 | MP0005360_urolithiasis | 3.99370876 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.65449473 |
| 4 | MP0005365_abnormal_bile_salt | 3.19029605 |
| 5 | MP0003252_abnormal_bile_duct | 2.91928245 |
| 6 | MP0005409_darkened_coat_color | 2.84618247 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.82317494 |
| 8 | MP0004130_abnormal_muscle_cell | 2.75373412 |
| 9 | MP0005275_abnormal_skin_tensile | 2.70625222 |
| 10 | MP0002009_preneoplasia | 2.47430830 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.41146984 |
| 12 | MP0005670_abnormal_white_adipose | 2.37115868 |
| 13 | MP0004510_myositis | 2.31337476 |
| 14 | MP0003045_fibrosis | 2.29166088 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.25501319 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.21453700 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.08171135 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.02396910 |
| 19 | MP0008057_abnormal_DNA_replication | 1.96715214 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.85893608 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 1.82020240 |
| 22 | MP0002166_altered_tumor_susceptibility | 1.79992871 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.79450836 |
| 24 | MP0000751_myopathy | 1.79076534 |
| 25 | MP0005451_abnormal_body_composition | 1.76772099 |
| 26 | MP0004233_abnormal_muscle_weight | 1.70100133 |
| 27 | MP0003646_muscle_fatigue | 1.68711438 |
| 28 | MP0005666_abnormal_adipose_tissue | 1.67693378 |
| 29 | MP0004859_abnormal_synaptic_plasticity | 1.64952460 |
| 30 | MP0008961_abnormal_basal_metabolism | 1.62782678 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.61427551 |
| 32 | MP0004381_abnormal_hair_follicle | 1.58789488 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.54746635 |
| 34 | MP0002254_reproductive_system_inflammat | 1.53426696 |
| 35 | MP0006138_congestive_heart_failure | 1.51069609 |
| 36 | MP0003329_amyloid_beta_deposits | 1.50231722 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.49827024 |
| 38 | MP0005083_abnormal_biliary_tract | 1.49183085 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.48768204 |
| 40 | MP0003690_abnormal_glial_cell | 1.47996679 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.47424325 |
| 42 | MP0000609_abnormal_liver_physiology | 1.44780386 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.41769259 |
| 44 | MP0002796_impaired_skin_barrier | 1.41515588 |
| 45 | MP0001666_abnormal_nutrient_absorption | 1.40584670 |
| 46 | MP0000383_abnormal_hair_follicle | 1.40521149 |
| 47 | MP0009840_abnormal_foam_cell | 1.37121367 |
| 48 | MP0000747_muscle_weakness | 1.36995114 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.35575684 |
| 50 | MP0001851_eye_inflammation | 1.35067764 |
| 51 | MP0010678_abnormal_skin_adnexa | 1.33055513 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.31015406 |
| 53 | MP0000759_abnormal_skeletal_muscle | 1.29501965 |
| 54 | MP0000733_abnormal_muscle_development | 1.28479019 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.27416918 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.27254381 |
| 57 | MP0005023_abnormal_wound_healing | 1.26160420 |
| 58 | MP0004084_abnormal_cardiac_muscle | 1.24818592 |
| 59 | MP0008438_abnormal_cutaneous_collagen | 1.24641170 |
| 60 | MP0002971_abnormal_brown_adipose | 1.24588714 |
| 61 | MP0002006_tumorigenesis | 1.22991740 |
| 62 | MP0004264_abnormal_extraembryonic_tissu | 1.22690001 |
| 63 | MP0000604_amyloidosis | 1.21830481 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 1.21361473 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.20906915 |
| 66 | MP0010368_abnormal_lymphatic_system | 1.20614417 |
| 67 | MP0000371_diluted_coat_color | 1.19914765 |
| 68 | MP0002108_abnormal_muscle_morphology | 1.19519416 |
| 69 | MP0002928_abnormal_bile_duct | 1.17511961 |
| 70 | MP0003868_abnormal_feces_composition | 1.13143045 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.12738688 |
| 72 | MP0004087_abnormal_muscle_fiber | 1.12481987 |
| 73 | MP0005375_adipose_tissue_phenotype | 1.10528969 |
| 74 | MP0008260_abnormal_autophagy | 1.10473277 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.10386756 |
| 76 | MP0002168_other_aberrant_phenotype | 1.07615581 |
| 77 | MP0005535_abnormal_body_temperature | 1.06901626 |
| 78 | MP0004270_analgesia | 1.06853902 |
| 79 | MP0004036_abnormal_muscle_relaxation | 1.06650049 |
| 80 | MP0010630_abnormal_cardiac_muscle | 1.06509734 |
| 81 | MP0005330_cardiomyopathy | 1.05701836 |
| 82 | MP0008004_abnormal_stomach_pH | 1.05677810 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.05479447 |
| 84 | MP0003303_peritoneal_inflammation | 1.04135335 |
| 85 | MP0005334_abnormal_fat_pad | 1.03259353 |
| 86 | MP0008775_abnormal_heart_ventricle | 1.02476822 |
| 87 | MP0002106_abnormal_muscle_physiology | 1.01328137 |
| 88 | MP0002060_abnormal_skin_morphology | 1.01285251 |
| 89 | MP0009046_muscle_twitch | 1.00033678 |
| 90 | MP0000579_abnormal_nail_morphology | 0.99781155 |
| 91 | MP0005332_abnormal_amino_acid | 0.98258479 |
| 92 | MP0001915_intracranial_hemorrhage | 0.95937806 |
| 93 | MP0003632_abnormal_nervous_system | 0.95213826 |
| 94 | MP0002909_abnormal_adrenal_gland | 0.94725450 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 0.94216948 |
| 96 | MP0003879_abnormal_hair_cell | 0.94067038 |
| 97 | MP0002078_abnormal_glucose_homeostasis | 0.92080754 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.90696596 |
| 99 | MP0005388_respiratory_system_phenotype | 0.90439307 |
| 100 | MP0002133_abnormal_respiratory_system | 0.90439307 |
| 101 | MP0004484_altered_response_of | 0.89388406 |
| 102 | MP0009278_abnormal_bone_marrow | 0.89320767 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.89277695 |
| 104 | MP0005448_abnormal_energy_balance | 0.88401594 |
| 105 | MP0004947_skin_inflammation | 0.87435420 |
| 106 | MP0003633_abnormal_nervous_system | 0.87322799 |
| 107 | MP0005369_muscle_phenotype | 0.86872667 |
| 108 | MP0000920_abnormal_myelination | 0.86113299 |
| 109 | MP0001958_emphysema | 0.85436149 |
| 110 | MP0000465_gastrointestinal_hemorrhage | 0.83753428 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83213554 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.82588310 |
| 113 | MP0003279_aneurysm | 0.82442719 |
| 114 | MP0002972_abnormal_cardiac_muscle | 0.82396658 |
| 115 | MP0003091_abnormal_cell_migration | 0.82369596 |
| 116 | MP0002269_muscular_atrophy | 0.81648232 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.81386376 |
| 118 | MP0008569_lethality_at_weaning | 0.80770145 |
| 119 | MP0001501_abnormal_sleep_pattern | 0.80237349 |
| 120 | MP0010234_abnormal_vibrissa_follicle | 0.79613139 |
| 121 | MP0005621_abnormal_cell_physiology | 0.79233010 |
| 122 | MP0009763_increased_sensitivity_to | 0.78437480 |
| 123 | MP0009764_decreased_sensitivity_to | 0.77920192 |
| 124 | MP0000015_abnormal_ear_pigmentation | 0.77146201 |
| 125 | MP0009115_abnormal_fat_cell | 0.76765364 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.76521299 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.76516835 |
| 128 | MP0004272_abnormal_basement_membrane | 0.76393712 |
| 129 | MP0000749_muscle_degeneration | 0.76301638 |
| 130 | MP0003828_pulmonary_edema | 0.75612539 |
| 131 | MP0003075_altered_response_to | 0.74912295 |
| 132 | MP0005620_abnormal_muscle_contractility | 0.73618212 |
| 133 | MP0001661_extended_life_span | 0.73100023 |
| 134 | MP0000427_abnormal_hair_cycle | 0.72503632 |
| 135 | MP0001784_abnormal_fluid_regulation | 0.72346907 |
| 136 | MP0005187_abnormal_penis_morphology | 0.72184776 |
| 137 | MP0003634_abnormal_glial_cell | 0.71647924 |
| 138 | MP0004858_abnormal_nervous_system | 0.71566646 |
| 139 | MP0002822_catalepsy | 0.71036997 |
| 140 | MP0004883_abnormal_blood_vessel | 0.70651044 |
| 141 | MP0005503_abnormal_tendon_morphology | 0.70165384 |
| 142 | MP0005387_immune_system_phenotype | 0.69778703 |
| 143 | MP0001790_abnormal_immune_system | 0.69778703 |
| 144 | MP0008874_decreased_physiological_sensi | 0.69719974 |
| 145 | MP0001544_abnormal_cardiovascular_syste | 0.68619361 |
| 146 | MP0005385_cardiovascular_system_phenoty | 0.68619361 |
| 147 | MP0000003_abnormal_adipose_tissue | 0.68168215 |
| 148 | MP0001873_stomach_inflammation | 0.66896447 |
| 149 | MP0003787_abnormal_imprinting | 0.66473000 |
| 150 | MP0004085_abnormal_heartbeat | 0.65630181 |
| 151 | MP0003656_abnormal_erythrocyte_physiolo | 0.65349460 |
| 152 | MP0005647_abnormal_sex_gland | 0.65217826 |
| 153 | MP0002419_abnormal_innate_immunity | 0.62743953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 3.21848270 |
| 2 | Hypoalphalipoproteinemia (HP:0003233) | 2.90623124 |
| 3 | Hyporeflexia of lower limbs (HP:0002600) | 2.86417208 |
| 4 | Epidermoid cyst (HP:0200040) | 2.85476246 |
| 5 | Xanthomatosis (HP:0000991) | 2.76068316 |
| 6 | Deep venous thrombosis (HP:0002625) | 2.74583875 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 2.73547598 |
| 8 | Myocardial infarction (HP:0001658) | 2.66437856 |
| 9 | Hyperkalemia (HP:0002153) | 2.65593724 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.62087040 |
| 11 | Subaortic stenosis (HP:0001682) | 2.62087040 |
| 12 | Complement deficiency (HP:0004431) | 2.57828737 |
| 13 | Dysmetric saccades (HP:0000641) | 2.57721622 |
| 14 | Macroorchidism (HP:0000053) | 2.54857025 |
| 15 | Overgrowth (HP:0001548) | 2.54298110 |
| 16 | Sudden death (HP:0001699) | 2.53642023 |
| 17 | Frequent falls (HP:0002359) | 2.51293118 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 2.45458723 |
| 19 | Ketosis (HP:0001946) | 2.44859718 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 2.44100824 |
| 21 | Mitral stenosis (HP:0001718) | 2.37515929 |
| 22 | Muscle fiber splitting (HP:0003555) | 2.36857899 |
| 23 | Obstructive sleep apnea (HP:0002870) | 2.36581389 |
| 24 | Osteolytic defects of the hand bones (HP:0009699) | 2.36321095 |
| 25 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36321095 |
| 26 | Lower limb amyotrophy (HP:0007210) | 2.35145060 |
| 27 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.35083363 |
| 28 | Urethral obstruction (HP:0000796) | 2.34142087 |
| 29 | Difficulty running (HP:0009046) | 2.33377125 |
| 30 | Right ventricular cardiomyopathy (HP:0011663) | 2.33299114 |
| 31 | Cerebral aneurysm (HP:0004944) | 2.32559316 |
| 32 | Type 1 muscle fiber predominance (HP:0003803) | 2.32136831 |
| 33 | Bundle branch block (HP:0011710) | 2.30214953 |
| 34 | Distal lower limb amyotrophy (HP:0008944) | 2.29714338 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.29573880 |
| 36 | Papillary thyroid carcinoma (HP:0002895) | 2.24755078 |
| 37 | Broad face (HP:0000283) | 2.23555262 |
| 38 | Ankyloglossia (HP:0010296) | 2.23552303 |
| 39 | Narrow palate (HP:0000189) | 2.23363802 |
| 40 | Vertebral arch anomaly (HP:0008438) | 2.22509775 |
| 41 | Syncope (HP:0001279) | 2.21907762 |
| 42 | Gingival bleeding (HP:0000225) | 2.21793536 |
| 43 | Hematochezia (HP:0002573) | 2.21733407 |
| 44 | Neonatal hypoglycemia (HP:0001998) | 2.21431298 |
| 45 | Hypoplastic ischia (HP:0003175) | 2.20910880 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.20313795 |
| 47 | Subacute progressive viral hepatitis (HP:0006572) | 2.19949848 |
| 48 | Blue irides (HP:0000635) | 2.19680293 |
| 49 | Arterial tortuosity (HP:0005116) | 2.18573403 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.18475182 |
| 51 | Hypolipoproteinemia (HP:0010981) | 2.17968419 |
| 52 | Periodontitis (HP:0000704) | 2.16787530 |
| 53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16660543 |
| 54 | Increased connective tissue (HP:0009025) | 2.16503150 |
| 55 | Turricephaly (HP:0000262) | 2.16211287 |
| 56 | Thick nail (HP:0001805) | 2.15772473 |
| 57 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.15138658 |
| 58 | Long toe (HP:0010511) | 2.13411022 |
| 59 | Ketoacidosis (HP:0001993) | 2.11862275 |
| 60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.11037169 |
| 61 | Hypoglycemic coma (HP:0001325) | 2.10579029 |
| 62 | Exercise-induced myalgia (HP:0003738) | 2.10180834 |
| 63 | Skin nodule (HP:0200036) | 2.09444039 |
| 64 | Asymmetric septal hypertrophy (HP:0001670) | 2.08362920 |
| 65 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.07541828 |
| 66 | Persistence of primary teeth (HP:0006335) | 2.07527204 |
| 67 | Heterotopia (HP:0002282) | 2.07405529 |
| 68 | Abnormality of the ischium (HP:0003174) | 2.06450011 |
| 69 | Lip pit (HP:0100267) | 2.05640260 |
| 70 | Pigmentary retinal degeneration (HP:0001146) | 2.05219673 |
| 71 | Colitis (HP:0002583) | 2.04127707 |
| 72 | Prolonged QT interval (HP:0001657) | 2.03980162 |
| 73 | Hypoplasia of the iris (HP:0007676) | 2.02970582 |
| 74 | Joint hemorrhage (HP:0005261) | 2.01736352 |
| 75 | EMG: neuropathic changes (HP:0003445) | 2.01245556 |
| 76 | Aneurysm (HP:0002617) | 2.00185745 |
| 77 | Vascular tortuosity (HP:0004948) | 1.99969311 |
| 78 | Germ cell neoplasia (HP:0100728) | 1.99645186 |
| 79 | Hemiplegia (HP:0002301) | 1.99469966 |
| 80 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.99427590 |
| 81 | Ventricular tachycardia (HP:0004756) | 1.98163094 |
| 82 | Abnormality of vision evoked potentials (HP:0000649) | 1.97228278 |
| 83 | Atrial fibrillation (HP:0005110) | 1.96560153 |
| 84 | Postural instability (HP:0002172) | 1.96535787 |
| 85 | Esophageal varix (HP:0002040) | 1.95251824 |
| 86 | Hydroxyprolinuria (HP:0003080) | 1.94749941 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 1.94749941 |
| 88 | Muscle fiber inclusion bodies (HP:0100299) | 1.93961581 |
| 89 | Truncal obesity (HP:0001956) | 1.93527334 |
| 90 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.93425966 |
| 91 | Abnormality of nail color (HP:0100643) | 1.92770323 |
| 92 | Drooling (HP:0002307) | 1.92764865 |
| 93 | Excessive salivation (HP:0003781) | 1.92764865 |
| 94 | Genetic anticipation (HP:0003743) | 1.91774327 |
| 95 | Acanthocytosis (HP:0001927) | 1.90898535 |
| 96 | Conjugated hyperbilirubinemia (HP:0002908) | 1.89609299 |
| 97 | Gingivitis (HP:0000230) | 1.88903923 |
| 98 | EMG: myopathic abnormalities (HP:0003458) | 1.88365092 |
| 99 | Ventricular fibrillation (HP:0001663) | 1.87966681 |
| 100 | Hyperammonemia (HP:0001987) | 1.87082689 |
| 101 | Scanning speech (HP:0002168) | 1.86257955 |
| 102 | Interstitial pulmonary disease (HP:0006530) | 1.86089154 |
| 103 | Absent frontal sinuses (HP:0002688) | 1.85709961 |
| 104 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.85433504 |
| 105 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.83994261 |
| 106 | Acute myeloid leukemia (HP:0004808) | 1.83677163 |
| 107 | Nemaline bodies (HP:0003798) | 1.83019579 |
| 108 | Prolonged partial thromboplastin time (HP:0003645) | 1.81708388 |
| 109 | Aortic dissection (HP:0002647) | 1.81601913 |
| 110 | Cerebral inclusion bodies (HP:0100314) | 1.81076904 |
| 111 | Laryngomalacia (HP:0001601) | 1.80365666 |
| 112 | Slow saccadic eye movements (HP:0000514) | 1.79569474 |
| 113 | Spontaneous hematomas (HP:0007420) | 1.79438463 |
| 114 | Advanced eruption of teeth (HP:0006288) | 1.78807972 |
| 115 | Dislocated radial head (HP:0003083) | 1.78690197 |
| 116 | Action tremor (HP:0002345) | 1.77487498 |
| 117 | Bowel incontinence (HP:0002607) | 1.77365370 |
| 118 | Global brain atrophy (HP:0002283) | 1.76723807 |
| 119 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.76561850 |
| 120 | Mitral valve prolapse (HP:0001634) | 1.75821836 |
| 121 | Primary atrial arrhythmia (HP:0001692) | 1.75742002 |
| 122 | Flat acetabular roof (HP:0003180) | 1.75702117 |
| 123 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.75072793 |
| 124 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.74755978 |
| 125 | Hemorrhage of the eye (HP:0011885) | 1.74435658 |
| 126 | Foot dorsiflexor weakness (HP:0009027) | 1.74426372 |
| 127 | Onion bulb formation (HP:0003383) | 1.74229068 |
| 128 | Abnormality of the common coagulation pathway (HP:0010990) | 1.73977339 |
| 129 | Abnormality of oral frenula (HP:0000190) | 1.72849809 |
| 130 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.72849221 |
| 131 | Facial diplegia (HP:0001349) | 1.72360209 |
| 132 | Neoplasm of the heart (HP:0100544) | 1.72334071 |
| 133 | Amyloidosis (HP:0011034) | 1.72305309 |
| 134 | Distal lower limb muscle weakness (HP:0009053) | 1.72238391 |
| 135 | Decreased motor nerve conduction velocity (HP:0003431) | 1.71074683 |
| 136 | Neurofibrillary tangles (HP:0002185) | 1.71031255 |
| 137 | Hyperglycemia (HP:0003074) | 1.70788336 |
| 138 | Heart block (HP:0012722) | 1.70721858 |
| 139 | Increased CSF protein (HP:0002922) | 1.70685911 |
| 140 | Febrile seizures (HP:0002373) | 1.69274371 |
| 141 | Abnormality of secondary sexual hair (HP:0009888) | 1.69265931 |
| 142 | Abnormality of the axillary hair (HP:0100134) | 1.69265931 |
| 143 | Milia (HP:0001056) | 1.69256521 |
| 144 | Focal seizures (HP:0007359) | 1.68832455 |
| 145 | Abnormality of purine metabolism (HP:0004352) | 1.67989315 |
| 146 | Sandal gap (HP:0001852) | 1.67725768 |
| 147 | Hyperglycinuria (HP:0003108) | 1.66128430 |
| 148 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.65543330 |
| 149 | Ventricular arrhythmia (HP:0004308) | 1.65040007 |
| 150 | Abnormality of the calf musculature (HP:0001430) | 1.64682512 |
| 151 | Atrioventricular block (HP:0001678) | 1.64662839 |
| 152 | Myoglobinuria (HP:0002913) | 1.63173249 |
| 153 | Broad metatarsal (HP:0001783) | 1.61624840 |
| 154 | Aortic aneurysm (HP:0004942) | 1.60939930 |
| 155 | Coarse hair (HP:0002208) | 1.60502843 |
| 156 | Increased IgE level (HP:0003212) | 1.60353091 |
| 157 | Impaired social interactions (HP:0000735) | 1.59578012 |
| 158 | Abnormal social behavior (HP:0012433) | 1.59578012 |
| 159 | Calf muscle hypertrophy (HP:0008981) | 1.59453890 |
| 160 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.59126729 |
| 161 | Hypoglycemic seizures (HP:0002173) | 1.58823631 |
| 162 | Hypochromic microcytic anemia (HP:0004840) | 1.58803131 |
| 163 | Generalized hypopigmentation of hair (HP:0011358) | 1.58438428 |
| 164 | Sensorimotor neuropathy (HP:0007141) | 1.58411588 |
| 165 | Abnormality of the foot musculature (HP:0001436) | 1.58146003 |
| 166 | Atrophic scars (HP:0001075) | 1.58010876 |
| 167 | Reticulocytosis (HP:0001923) | 1.57132875 |
| 168 | Relative macrocephaly (HP:0004482) | 1.56686360 |
| 169 | Recurrent bacterial skin infections (HP:0005406) | 1.55698268 |
| 170 | Mask-like facies (HP:0000298) | 1.55337151 |
| 171 | Abnormal large intestine physiology (HP:0012700) | 1.55256243 |
| 172 | Cubitus valgus (HP:0002967) | 1.55162604 |
| 173 | Abnormality of complement system (HP:0005339) | 1.54449881 |
| 174 | Status epilepticus (HP:0002133) | 1.53184996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 3.09947331 |
| 2 | CAMK1G | 3.03992402 |
| 3 | EEF2K | 2.66890009 |
| 4 | INSRR | 2.43624707 |
| 5 | AKT3 | 2.28036531 |
| 6 | SIK1 | 2.27798213 |
| 7 | TAOK3 | 2.17444552 |
| 8 | TTN | 2.14287779 |
| 9 | JAK1 | 2.08039277 |
| 10 | RIPK1 | 2.05394286 |
| 11 | PRPF4B | 1.99335721 |
| 12 | CDK12 | 1.95219860 |
| 13 | DAPK2 | 1.90709217 |
| 14 | MAP3K13 | 1.88493133 |
| 15 | RIPK4 | 1.87491896 |
| 16 | LMTK2 | 1.86461695 |
| 17 | SIK2 | 1.86440637 |
| 18 | SGK3 | 1.71718593 |
| 19 | TYK2 | 1.71231990 |
| 20 | EPHA3 | 1.69995723 |
| 21 | FRK | 1.68956744 |
| 22 | MAP3K7 | 1.67661620 |
| 23 | SGK2 | 1.55785383 |
| 24 | MAP3K14 | 1.50890785 |
| 25 | LATS1 | 1.47138862 |
| 26 | NLK | 1.41734025 |
| 27 | FGFR4 | 1.39227913 |
| 28 | FGFR3 | 1.37934722 |
| 29 | PIK3CG | 1.36234690 |
| 30 | PTK6 | 1.33888856 |
| 31 | KSR2 | 1.33023498 |
| 32 | MAP3K6 | 1.28169680 |
| 33 | PRKAA2 | 1.25126216 |
| 34 | BLK | 1.24757165 |
| 35 | TRIB3 | 1.24331833 |
| 36 | IKBKE | 1.21849695 |
| 37 | STK38 | 1.21156969 |
| 38 | DMPK | 1.18228420 |
| 39 | IRAK3 | 1.17193688 |
| 40 | NEK6 | 1.14827375 |
| 41 | BRD4 | 1.10516232 |
| 42 | MAP3K4 | 1.10414517 |
| 43 | PHKG2 | 1.10294031 |
| 44 | PHKG1 | 1.10294031 |
| 45 | MAP3K10 | 1.07059526 |
| 46 | PRKCH | 1.04656947 |
| 47 | NTRK3 | 1.04105458 |
| 48 | FGFR2 | 0.99895459 |
| 49 | PRKAA1 | 0.99427080 |
| 50 | JAK2 | 0.97001564 |
| 51 | SGK494 | 0.95909088 |
| 52 | SGK223 | 0.95909088 |
| 53 | SGK1 | 0.95454529 |
| 54 | NEK9 | 0.94678221 |
| 55 | PDGFRB | 0.90701773 |
| 56 | WNK1 | 0.90384646 |
| 57 | FER | 0.89983733 |
| 58 | PKN2 | 0.87980727 |
| 59 | PDK1 | 0.87506772 |
| 60 | OBSCN | 0.86903074 |
| 61 | MAP2K4 | 0.86437630 |
| 62 | PDPK1 | 0.86163802 |
| 63 | MTOR | 0.82373376 |
| 64 | ZAP70 | 0.82283561 |
| 65 | MAP3K9 | 0.80545802 |
| 66 | MET | 0.79044553 |
| 67 | CAMK4 | 0.78867207 |
| 68 | JAK3 | 0.78756714 |
| 69 | HCK | 0.78570867 |
| 70 | CDC42BPA | 0.78546743 |
| 71 | ERN1 | 0.76646410 |
| 72 | PKN1 | 0.76421365 |
| 73 | MAPK12 | 0.76319454 |
| 74 | MARK2 | 0.75816867 |
| 75 | MELK | 0.75704325 |
| 76 | SCYL2 | 0.75438208 |
| 77 | MAP3K1 | 0.74978654 |
| 78 | PIK3CA | 0.73887633 |
| 79 | MAP2K3 | 0.73683279 |
| 80 | EPHB1 | 0.72695058 |
| 81 | RET | 0.70203584 |
| 82 | ERBB2 | 0.70064561 |
| 83 | ICK | 0.69195895 |
| 84 | TGFBR2 | 0.68991604 |
| 85 | MAPKAPK3 | 0.68230593 |
| 86 | FES | 0.67528167 |
| 87 | PDGFRA | 0.67416284 |
| 88 | BMPR2 | 0.66705534 |
| 89 | MAP3K2 | 0.65670018 |
| 90 | MAPK7 | 0.65572711 |
| 91 | KIT | 0.65074916 |
| 92 | STK11 | 0.63956272 |
| 93 | PAK6 | 0.63338640 |
| 94 | CAMKK1 | 0.62391741 |
| 95 | MAP4K1 | 0.61140743 |
| 96 | CSK | 0.60929208 |
| 97 | TBK1 | 0.59968284 |
| 98 | MAPK11 | 0.59877124 |
| 99 | NUAK1 | 0.57934163 |
| 100 | CHUK | 0.56993638 |
| 101 | PRKD1 | 0.56420533 |
| 102 | CDK6 | 0.55910156 |
| 103 | CAMK1 | 0.55391886 |
| 104 | EPHA4 | 0.53839647 |
| 105 | NTRK1 | 0.53686336 |
| 106 | CDK9 | 0.53124020 |
| 107 | RPS6KA2 | 0.51020436 |
| 108 | RAF1 | 0.50639281 |
| 109 | RPS6KA3 | 0.49417963 |
| 110 | ITK | 0.49288851 |
| 111 | CAMKK2 | 0.48820763 |
| 112 | PDK2 | 0.48045786 |
| 113 | NTRK2 | 0.48039268 |
| 114 | PRKCQ | 0.47145703 |
| 115 | MAPK10 | 0.46795864 |
| 116 | PTK2 | 0.46718073 |
| 117 | KSR1 | 0.46530659 |
| 118 | FYN | 0.46040148 |
| 119 | RPS6KB1 | 0.46015296 |
| 120 | PAK2 | 0.44195732 |
| 121 | IRAK1 | 0.44046681 |
| 122 | BTK | 0.42893510 |
| 123 | MAP3K3 | 0.42636855 |
| 124 | BMX | 0.42382679 |
| 125 | HIPK2 | 0.42191470 |
| 126 | EGFR | 0.41755878 |
| 127 | PAK3 | 0.41449346 |
| 128 | CDK5 | 0.40096211 |
| 129 | PRKACG | 0.40008115 |
| 130 | TRPM7 | 0.39811177 |
| 131 | CSF1R | 0.38802679 |
| 132 | MST1R | 0.37557062 |
| 133 | TAOK1 | 0.36853048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.96252651 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.11143523 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.95092641 |
| 4 | Lysine degradation_Homo sapiens_hsa00310 | 1.95007335 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.94548894 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85170804 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83510910 |
| 8 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.79721602 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72265216 |
| 10 | ABC transporters_Homo sapiens_hsa02010 | 1.61970321 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 1.53665312 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53198605 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.51917632 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46718311 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42164621 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 1.36866150 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36595355 |
| 18 | Endometrial cancer_Homo sapiens_hsa05213 | 1.36445642 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.35832344 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.33194546 |
| 21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.32821010 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32571698 |
| 23 | Adherens junction_Homo sapiens_hsa04520 | 1.30860371 |
| 24 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.30802628 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.29491952 |
| 26 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.29376842 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26199058 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25125107 |
| 29 | Focal adhesion_Homo sapiens_hsa04510 | 1.23703868 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21704028 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19260127 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16250006 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.15410349 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14616745 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14108879 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.13495927 |
| 37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.13028388 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11863492 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10486847 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09761697 |
| 41 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.05170115 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.04539177 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03312771 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03106325 |
| 45 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.01780220 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01399913 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95387091 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93926793 |
| 49 | Prostate cancer_Homo sapiens_hsa05215 | 0.92984431 |
| 50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87913512 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87738417 |
| 52 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87604505 |
| 53 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87119555 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85840572 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85756959 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 0.83257271 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82670055 |
| 58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81963470 |
| 59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81431220 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81267349 |
| 61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.81140247 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80234375 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79242103 |
| 64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78984292 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77497653 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76623409 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76338650 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.75591180 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.75251882 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75170587 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75071536 |
| 72 | Insulin secretion_Homo sapiens_hsa04911 | 0.73891712 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73711397 |
| 74 | Long-term depression_Homo sapiens_hsa04730 | 0.73555222 |
| 75 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73138283 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.73133904 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71439612 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71052543 |
| 79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70850221 |
| 80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70565808 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70432117 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69718952 |
| 83 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.68794876 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68654440 |
| 85 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68099314 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.67700336 |
| 87 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66931638 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66346976 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66266925 |
| 90 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64993170 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64831139 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64292363 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63592554 |
| 94 | Circadian entrainment_Homo sapiens_hsa04713 | 0.63415928 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62812231 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.61569286 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.61479951 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61384416 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61011134 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60725548 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58619738 |
| 102 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54714781 |
| 103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53467389 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53444584 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53358447 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.53279100 |
| 107 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.53092637 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52994477 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52740333 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.51869934 |
| 111 | Hepatitis B_Homo sapiens_hsa05161 | 0.51597717 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51234652 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50697445 |
| 114 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49476261 |
| 115 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49281899 |
| 116 | Nicotine addiction_Homo sapiens_hsa05033 | 0.47956508 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47381675 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.47240570 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46769197 |
| 120 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45997920 |
| 121 | Long-term potentiation_Homo sapiens_hsa04720 | 0.44781347 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.44427137 |
| 123 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44157857 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44147426 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | 0.44044337 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43824356 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43581194 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.42471142 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42245909 |
| 130 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41730050 |
| 131 | Platelet activation_Homo sapiens_hsa04611 | 0.40738059 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40261954 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38081832 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37707509 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.37464354 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37267223 |
| 137 | Tuberculosis_Homo sapiens_hsa05152 | 0.37245998 |
| 138 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37171094 |
| 139 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36989882 |
| 140 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.36750285 |
| 141 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36447691 |

